Clinical Trial Update: A Study of E6011 in Participants With Active Crohn's Disease [Phase 2]

View source ↗

Summary

Completed Phase 2 trial of E6011 in active Crohn's disease; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• E6011

Snippet

Sponsor: EA Pharma Co., Ltd. | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2025-04-02